MTI Viewpoints
Insights shared by industry relative to healthcare and the advancement of medical technology.
Aneesh Deshpande is a Hardware Engineer at Medtronic specializing in neuromodulation and neurostimulation platforms. He focuses on integrating complex medical device systems, hardware, firmware, and telemetry to ensure safe, reliable performance. An expert in system-level validation and data integrity, Aneesh advocates for early-stage integration and practical AI adoption to help teams build resilient, audit-ready engineering workflows.
The Problem: The Space Between the Subsystems
A system crash is loud and fixable. The real nightmare is a system that appears flawless while quietly corrupting data during a clinical trial. In my career hunting silent killers in neurostimulation platforms, I’ve learned one truth: the interface is where the real risk lives.
Catastrophic failures rarely stem from isolated hardware bugs. They breed where hardware, firmware, wireless telemetry, and clinical workflows intersect. These silent data integrity failures can invalidate entire research efforts without real-time detection, squeezing V&V Engineers between exploding complexity and compressed timelines.
The Context: The MedTech Ecosystem
In MedTech R&D, my job is ensuring complex neuromodulation systems reliably transfer data and run algorithms without compromising safety. This requires maintaining an airtight line of end-to-end traceability across four main domains:
The architecture of these systems is highly layered out of necessity, prioritizing data integrity, recoverability, deterministic behavior, verification coverage, and traceability.
A typical system splits across four main domains:
- Implant Layer: High-density neural sensing electrodes, stimulation delivery circuitry, embedded processing subsystems, and ultra-low-power on-device memory.
- Telemetry Layer: The wireless communication stack, data offload protocols, inductive recharger links, and real-time configuration syncs.
- Experiment Layer: Clinician-facing implantable stimulator configuration software, study-space data frameworks, and research data collection interfaces.
- Data & Validation Layers: Non-volatile event logs, memory usage analytics, automated test scripts, hardware-in-the-loop (HIL) testing rigs, and rigorous traceability documentation.
Medical device development demands uncompromising adherence to strict design controls, verification, risk management, and traceability frameworks. The ultimate engineering challenge isn’t just building the device; it’s maintaining a completely airtight, end-to-end line of traceability from basic system requirements all the way through implementation to validation evidence even across rapidly shifting hardware and firmware revisions.
Because of this complexity, my approach has had to change. Verifying isolated components just doesn’t cut it anymore. We have to validate how they interact.
My Approach: Structured Correlation and Validation First
Efficiency in debugging comes from proving what is working, systematically shrinking the scope to isolate the root cause. My primary strategy is structured log correlation, aligning device logs, memory calculations, and firmware events on a single timeline to reveal anomalies that a single dataset would miss.
My go-to strategy here is structured log correlation. I routinely line up device event logs, configuration exports, register memory calculations, test timestamps, and firmware events on a single timeline. Subtle system anomalies never show up in a single dataset. The answer usually only emerges after you normalize multiple data sources and force them into a unified view.
When deploying AI in regulated environments, we focus on productivity over production models. Using retrieval-based systems to navigate legacy documentation saves our teams 40% of their time while keeping human engineers in the review loop to ensure regulatory compliance.
The Evidence: Battles at the Interfaces
I once investigated a “software bug” that was actually a legacy configuration assumption. This changed my approach: I now validate configuration parameters as aggressively as functional code.
In another project, intermittent dropouts occurred only after 36 hours of continuous stress. The cause lived at the intersection of memory limits and telemetry rates. This taught us that coherent debugging requires establishing data normalization and automated correlation workflows early in the design phase.
The Strategy: Three Steps for Early Integration
To kill off interface risks before they reach the highly expensive verification phase, technical teams need to implement a formal, three-part procedural framework:
- Co-Design Integration Test Cases: Systems Integration Engineers must build and run integration test suites before the physical hardware design is locked down. Writing these tests early forces hardware, firmware, and software silos to agree on exact boundary definitions before a single component is fabricated.
- Standardize Time: Normalize and synchronize precise timestamps across all system event logs, wireless telemetry packets, and firmware headers during initial development. Without a unified time parameter, matching up disparate data sources into a single timeline is mathematically impossible.
- Assume Assumptions are Wrong: Task the V&V team with treating configuration assumptions exactly like functional code. Validate every single legacy configuration protocol and default parameter through rigorous boundary testing instead of just relying on historical compliance.
The Opinion: The Perils of Hype and Fragmentation
What drives me crazy about the current state of MedTech R&D is this stubborn tendency to treat hardware, firmware, and software like isolated islands. The most serious defects don’t start within a single subsystem; they appear at the boundaries where those systems talk to each other. On a recent project, our timeline took a massive hit because integration testing started far too late. The hardware was spun, the firmware was written, and the individual requirements were technically met but cross-subsystem testing didn’t start until each separate team considered their own work “done.” The lesson was obvious: you have to integrate much earlier than feels comfortable.
AI cannot fix a broken engineering workflow; it only accelerates existing inefficiencies. While organizations rush to adopt AI, they often ignore knowledge fragmentation where vital tribal knowledge is scattered across unstructured threads. For overall engineering infrastructure, explainability and traceability matter more than black-box predictive gains.
To be fair, AI definitely has a place in testing. Its ability to spot non-linear patterns in massive datasets can augment human reasoning during system-level tests, catching complex timing issues that rule-based systems might miss. For example, a well-defined AI algorithm can be incredibly successful at spotting specific signal artifacts in noisy neural recordings. But for overall engineering infrastructure in a regulated space, explainability and traceability matter far more than small, black-box gains in predictive accuracy.
A massive risk most teams ignore amidst all the AI hype is knowledge fragmentation. Vital engineering tribal knowledge ends up scattered across personal emails, unstructured chat threads, transient test reports, and individual engineers’ heads. That introduces severe operational risk the second a project scales or a core team member walks out the door.
The Takeaway: Navigating the Next Three Years
AI-assisted verification will be standard within three years, reflected in the FDA’s ongoing AI/ML guidance. However, automated tools require human guardrails. Reasoning at the system level remains an irreplaceable asset.
However, automated tools are only as good as the guardrails we build around them. Human, system-level reasoning is still an irreplaceable asset.
My advice is simple: don’t specialize in an isolated subsystem. Understand how they communicate. Technical teams don’t need more tools; they need repeatable processes for turning complex interfaces into trustworthy medical products.